TG Therapeutics Inc.
Organization details
- Legal name
- TG Therapeutics Inc.
- Former names
- Manhattan Pharmaceuticals Inc Atlantic Technology Ventures Inc Atlantic Pharmaceuticals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TGTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001001316
- EIN
- 36-3898269
- Wikidata ID
- Q106301317
Board of directors
-
Daniel Hume · DirectorSince 2023
-
Kenneth Hoberman · DirectorSince 2023
-
Laurence N. Charney · DirectorSince 2023
-
Michael S. Weiss · Director · CEOSince 2023
-
Sagar Lonial · DirectorSince 2023
-
Yann Echelard · DirectorSince 2023
Chief executives
Board connections
4 of this board's directors also sit on 5 other boards. 3 are in the same sector.
-
Fortress Biotech Inc. Same sectorvia Michael S. Weiss
- via Daniel Hume
- via Laurence N. Charney
-
Mustang Bio Inc. Same sectorvia Michael S. Weiss
-
Nuvectis Pharma Inc. Same sectorvia Kenneth Hoberman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $437,650
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Laurence N. Charney Director | Open-market sale | −5,000 | $54.96 | $274,800 |
| Aug 7, 2026 | Laurence N. Charney Director | Gift | −500 | — | — |
| Aug 7, 2026 | Laurence N. Charney Director | Gift | −450 | — | — |
| Aug 6, 2026 | Laurence N. Charney Director | Gift | −5,100 | — | — |
| Jan 29, 2026 | Laurence N. Charney Director | Gift | −13,197 | — | — |
| Jan 28, 2026 | Laurence N. Charney Director | Gift | −30,000 | — | — |
| Jan 8, 2026 | Michael S. Weiss Director, Officer (CEO) | Grant or award | +622,000 | — | — |
| Jan 8, 2026 | Power Sean A Officer (CFO) | Grant or award | +90,000 | — | — |
| Nov 24, 2025 | Yann Echelard Director | Open-market sale | −5,000 | $32.57 | $162,850 |
| Nov 5, 2025 | Michael S. Weiss Director, Officer (CEO) | Gift | −3,865,126 | — | — |
| Nov 5, 2025 | Michael S. Weiss Director, Officer (CEO) | Gift | −803,717 | — | — |
| Sep 11, 2025 | Sagar Lonial Director | Open-market sale | −20,852 | $32.24 | $672,268 |
| Jun 13, 2025 | Yann Echelard Director | Open-market sale | −10,000 | $36.94 | $369,400 |
| Jun 12, 2025 | Yann Echelard Director | Grant or award | +14,718 | — | — |
| Jun 12, 2025 | Laurence N. Charney Director | Grant or award | +21,408 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about TG Therapeutics Inc.
Who is the CEO of TG Therapeutics Inc.?
Michael S. Weiss is TG Therapeutics Inc.'s CEO and President.
How many directors are on TG Therapeutics Inc.'s board?
TG Therapeutics Inc.'s board has 6 directors: Daniel Hume, Kenneth Hoberman, Laurence N. Charney, Michael S. Weiss, Sagar Lonial and Yann Echelard.
Are TG Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, TG Therapeutics Inc. insiders made no open-market purchases and sold $437,650 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tg-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.